BIIB vs LYB · P/E 21, rev $9.89B vs P/E 21, rev $16.37B
Biogen Inc (BIIB) versus LyondellBasell Industries NV (LYB) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
LyondellBasell Industries NV (LYB) is a specialty chemicals company listed on US.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported LYB revenue for 2026-06-30 was $16.37B. Net income was $684.0M. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. LYB currently screens at market cap $19.93B and trailing P/E 21.5.
Not investment advice. Open the BIIB and LYB stock pages for the full models.
Not investment advice.